Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomized clinical trial.
Jin P, Liu Q, Chen W, Guo X, Jiang H, Zhang R, Ding M, Zhang K, Cao Z, He J, Jia S, Wei M, Hu Y, Cui L, Wang J, Li Z, Zhang X, Xia X, Wu Y, Zhou L, Zhu Y, Gao C, Zhang T, Zhu F, Zeng G, Zhu L, Li J.
Jin P, et al. Among authors: ding m.
Expert Rev Vaccines. 2024 Nov 11. doi: 10.1080/14760584.2024.2425283. Online ahead of print.
Expert Rev Vaccines. 2024.
PMID: 39523878